Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
11-2017 | 08-2017 | 05-2017 | 03-2017 | 02-2017 | |
Operating Expenses | 277 | 0 | 96 | 96 | 12 |
Operating Income | -277 | N/A | -96 | -96 | -12 |
Interest Expense | 0 | 0 | 1 | 0 | 1 |
Other Income | 0 | 0 | 0 | -1 | 0 |
Pre-tax Income | -277 | 0 | -97 | -97 | -13 |
Net Income Continuous | -277 | N/A | -97 | -13 | -13 |
Net Income | $-277 | $N/A | $-97 | $-97 | $-13 |
EPS Basic Total Ops | -0.30 | N/A | -0.15 | N/A | 0.00 |
EPS Basic Continuous Ops | -0.37 | N/A | -0.16 | N/A | -0.03 |
EPS Diluted Total Ops | -0.30 | N/A | -0.15 | N/A | 0.00 |
EPS Diluted Continuous Ops | -0.37 | N/A | -0.16 | N/A | -0.03 |
EBITDA(a) | $-277 | $N/A | $-96 | $-96 | $-12 |